Showing results (401-410 of 5,003) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|February 11, 2003
Protracted radiotherapy treatment duration in medulloblastomaArnold C Paulino, B-Chen Wen, Nina A Mayr, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancerAlberto Zaniboni, Andrea Ardizzoni, Filippo De Marinis, et al.
American Journal of Clinical Oncology|February 11, 2003
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II studyFilippo Montemurro, Gabriella Choa, Roberto Faggiuolo, et al.
American Journal of Clinical Oncology|August 1, 1993
Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesisK Mori, Y Saito, K Tominaga
American Journal of Clinical Oncology|June 1, 1993
Diastolic hypertension in Wilms' tumor survivors: a late effect of treatment? A report from the National Wilms' Tumor Study GroupJ Z Finklestein, P Norkool, D M Green, et al.
American Journal of Clinical Oncology|April 1, 1993
Antiestrogenic potency of toremifene and tamoxifen in postmenopausal womenH D Homesley, I Shemano, R A Gams, et al.
American Journal of Clinical Oncology|April 1, 1993
The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic breast cancer patientsR L Theriault, G Fraschini, F A Holmes, et al.
American Journal of Clinical Oncology|April 1, 1993
Piritrexim-induced pulmonary toxicityR de Wit, J Verweij, R Slingerland, et al.
American Journal of Clinical Oncology|April 1, 1993
A phase II trial of medroxyprogesterone acetate in epithelial ovarian cancers. A Gynecologic Oncology Group studyJ Malfetano, J B Beecham, B N Bundy, et al.
American Journal of Clinical Oncology|April 1, 1993
Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology GroupA Chang, M Hunt, D R Parkinson, et al.
Pageof 501